课题基金 / 基金详情

Mechanism of osteoclastogenesis inhibitory action by interleukin 18

Mechanism of osteoclastogenesis inhibitory action by interleukin 18
白细胞介素18抑制破骨细胞生成的机制
批准号:
09671905
负责人:
UDAGAWA Nobuyuki
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

UDAGAWA Nobuyuki的其他基金

相似基金

相关文献

中文摘要
翻译
IL-18在体外抑制破骨细胞(CCL)的形成,而不依赖于IFN-γ的产生,这一点可通过加入GM-CSF的中和抗体来消除。检查了使用野生型成骨细胞与GM-CSF -/-脾细胞或GM-CSF -/-成骨细胞与野生型脾细胞的相互共培养物。需要野生型脾细胞来引发对IL-18的应答,表明脾来源的细胞是IL-18靶标。由于T细胞在脾细胞群中占很大比例,因此检查了T细胞在破骨细胞生成中的作用。取出总T细胞并以各种组合补充。在GM-CSF -/-共培养物中加入野生型T细胞恢复了IL-18对破骨细胞生成的抑制作用。T细胞的主要亚群,CD 4和CD 8 +^+,也被单独耗尽。加入CD 4 ^+或CD 8 ^+野生型T细胞可以恢复IL-18在GM-CSF -/-背景下的作用,而当加入CD 4 ^+或CD 8 ^+ GM-CSF -/- T细胞到野生型共培养物中时,IL-18则无效。这些结果突出了T细胞参与IL-18诱导的CCL抑制,并为新的CCL抑制途径提供了证据,其中IL-18抑制CCL形成,这是由于对T细胞的作用促进了GM-CSF的释放,GM-CSF又作用于CCL前体。
英文摘要
IL-18 inhibits osteoclast (CCL) formation in vitro independent of IFN-gamma production, and this was abolished by the addition of neutralizing antibodies to GM-CSF.We now establish that IL-18 was unable to inhibit CCL formation in cocultures using GM-CSF-deficient mice (GM-CSF-/-). Reciprocal cocultures using either wild-type osteoblasts with GM-CSF -/- spleen cells or GM-CSF -/- osteoblasts with wild-type spleen cells were examined. Wild-type spleen cells were required to elicit a response to IL-18 indicating that cells of splenic origin were the IL-18 target. As T cells comprise a large proportion of the spleen cell population, the role of T cells in osteoclastogenesis was examined. Total T cells were removed and repleted in various combinations. Addition of wild-type T cells to a GM-CSF -/- coculture restored IL-18 inhibition of osteoclastogenesis. Major subsets of T cells, 0D4 and CD8+^+, were also individually depleted. Addition of either CD4^+ or CD8^+ wild-type T cells restored IL-18 action in a GM-CSF -/- background, while IL-18 was ineffective when either CD4^+ or CD8^+ GM-CSF -/- T cells were added to a wild-type coculture. These results highlight the involvement of T cells in IL-18-induced CCL inhibition and provide evidence for a new CCL inhibitory pathway whereby IL-18 inhibits CCL formation due to action upon T cells promoting the release of GM-CSF, which in turn acts upon CCL precursors.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
Katayama,Y.,et al.: "Casein kinase 2 phosphorylation of recombinant rat osteopontin enhances adhesion of osteoclasts but not osteoblasts." J.Cell.Physiol.176. 179-187 (1998)
Katayama, Y., et al.:“重组大鼠骨桥蛋白的酪蛋白激酶 2 磷酸化可增强破骨细胞的粘附,但不会增强成骨细胞的粘附。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nakamura,I.,et al.: "Lack of vacuolar proton ATPase association with the cytoskeleton in osteoclasts of osteosclerotic (oc/oc) mice." FEBS Lett.401. 207-212 (1997)
Nakamura,I.,et al.:“骨硬化 (oc/oc) 小鼠破骨细胞中缺乏与细胞骨架相关的液泡质子 ATP 酶。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Udagawa, N., et al.: "Interleukin-18(interfero-γ-inducing factor)is produced by osteoblasts and acts via granulocyte/macrophage-colony stimulating factor and not via interferon-γ to inhibit osteoclast formation." J.Exp.Med.185. 1005-1012 (1997)
Udakawa, N. 等人:“Interleukin-18(干扰素 γ 诱导因子)由成骨细胞产生,通过粒细胞/巨噬细胞集落刺激因子而不是干扰素 γ 抑制破骨细胞形成。” .医学185.1005-1012(1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tsurukai,T.,et al.: "Isolation and characterization of osteoclast precursors that differentiate into osteoclasts on calvarial cells within a short period of time." J.Cell.Physiol.177. 26-35 (1998)
Tsurukai,T.,et al.:“破骨细胞前体的分离和表征,这些前体在短时间内在颅骨细胞上分化为破骨细胞。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 20 条
    Exploration of seeds for development of a new drug targeting Bone-Vascular-Spleen axis
    • 批准号:
      25670793
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2013
    • 负责人:
      UDAGAWA Nobuyuki
    • 依托单位:
    Analysis of bone remodeling mechanism between osteoblasts and osteoclasts for the alveolar bone regeneration
    • 批准号:
      24390417
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.73万
    • 财政年份:
      2012
    • 负责人:
      UDAGAWA Nobuyuki
    • 依托单位:
    Basic research on development of new treatment of alveolar bone regeneration
    • 批准号:
      21390498
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.73万
    • 财政年份:
      2009
    • 负责人:
      UDAGAWA Nobuyuki
    • 依托单位:
    Elucidation of the regulated mechanism of bone metabolism by osteoclastic transcytosis.
    • 批准号:
      19390476
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.15万
    • 财政年份:
      2007
    • 负责人:
      UDAGAWA Nobuyuki
    • 依托单位:
    海外基金